SCIDOT-46. MicroRNA NANOCELL THERAPY FOR GLIOBLASTOMA

Therapeutic resistance stemming from inter and intra-tumoral heterogeneity is a significant impediment towards development of effective therapeutics for glioblastoma. We hypothesized that microRNAs can potentially counteract resistance emanating from such heterogeneity as they simultaneously modulat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Babar Khan, Muhammad, Ruggieri, Rosamaria, Tran, Nhan, Sarkaria, Jann, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Boockvar, John, Symons, Marc
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Abstracts from the 3rd Sno-Scidot Joint Conference on Therapeutic Delivery to the CNS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846215/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1182
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires